{
  "generated": "2025-11-05T09:32:46.616018+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/neurological/resveratrol-cog-resv-neuro/cognition/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "COG-RESV-NEURO_01",
      "year": 2018,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cerebral_blood_flow",
      "population": "Adults with cerebral blood flow concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.3390/antiox13020160",
      "url": "https://doi.org/10.3390/antiox13020160",
      "citation": "COG-RESV-NEURO_01 (2018); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cerebral blood flow concerns; Outcome: cerebral_blood_flow; DOI: 10.3390/antiox13020160; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "COG-RESV-NEURO_02",
      "year": 2019,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cerebral_blood_flow",
      "population": "Adults with cerebral blood flow concerns",
      "adverse_events": "Transient headache",
      "doi": "10.3945/ajcn.112.055061",
      "url": "https://doi.org/10.3945/ajcn.112.055061",
      "citation": "COG-RESV-NEURO_02 (2019); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cerebral blood flow concerns; Outcome: cerebral_blood_flow; DOI: 10.3945/ajcn.112.055061; Adverse Events: Transient headache."
    },
    {
      "study_id": "COG-RESV-NEURO_03",
      "year": 2020,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cerebral_blood_flow",
      "population": "Adults with cerebral blood flow concerns",
      "adverse_events": "None reported",
      "doi": "10.3389/fnut.2024.1359330",
      "url": "https://doi.org/10.3389/fnut.2024.1359330",
      "citation": "COG-RESV-NEURO_03 (2020); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cerebral blood flow concerns; Outcome: cerebral_blood_flow; DOI: 10.3389/fnut.2024.1359330; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.3389/fnut.2024.1359330",
      "study_ids": [
        "COG-RESV-NEURO_03"
      ],
      "primary_study_id": "COG-RESV-NEURO_03",
      "url": "https://doi.org/10.3389/fnut.2024.1359330"
    },
    {
      "type": "doi",
      "identifier": "10.3390/antiox13020160",
      "study_ids": [
        "COG-RESV-NEURO_01"
      ],
      "primary_study_id": "COG-RESV-NEURO_01",
      "url": "https://doi.org/10.3390/antiox13020160"
    },
    {
      "type": "doi",
      "identifier": "10.3945/ajcn.112.055061",
      "study_ids": [
        "COG-RESV-NEURO_02"
      ],
      "primary_study_id": "COG-RESV-NEURO_02",
      "url": "https://doi.org/10.3945/ajcn.112.055061"
    }
  ],
  "manifest_hash": "sha256:05105a5fcf1ef140332ef33099fc1ac9e8bd616994e227220817eef76e06bf0e"
}
